After successfully completing initial safety and feasibility trials, Quietmind Foundation, in cooperation with Texas A&M and Baylor Research Institute, enrolled 100 adults (50-85) with memory loss for a new innovative clinical study. This study recently completed data collection and reports are being prepared with reportedly very encouraging preliminary results.  

About The Clinical Trial
In cooperation with Texas A&M University's Dept. of Neurosurgery, Quietmind Foundation enrolled individuals age 50-85 years experiencing memory problems and who had been independently diagnosed with early to mid-stage dementia to participate in this trial. The study used low-level infrared light stimulation directed to the head. The stimulation sessions were conducted at home, twice daily, for 5 minutes over 60 consecutive days. The trial was randomized, placebo controlled and double blinded.
Trial Procedure:
Individuals that matched the clinical trial eligibility criteria went through two unique assessments at the start, mid-point, and ending of the trial period. 

1. First, subjects completed a Quantitative EEG assessment. This assessment involved wearing a cap with sensors that record the brain's electrical activity. This is a non-invasive procedure and completed in less than 30-minutes. This assessment is conducted in-person.
2. Subjects then completed a standardized memory assessment. This assessment takes an hour and was conducted remotely by the study neuropsychologist.

Following these first two assessments, participants received a light therapy device that they will wear for 5-minutes, twice daily for 2 months. This device uses safe LED lights that stimulate blood flow and reduce inflammation in the brain.

Participants repeated the EEG and cognitive assessments twice more during the two month trial.

Dr. Marvin Berman, PhD CBT is the founder of the Quietmind Foundation and leading the research trial.